Sign inJoin waitlistJoin the waitlist

Han Tun

Professor of Medicine · Mayo Clinic College of Medicine and Science

Credentials: · · · · ·

History

Research Program Specialist · Geisel School of Medicine
Present
Mayo Clinic College of Medicine and Science
Present

Hematology
2001–2002
Internal Medicine
1998–2001
Psychiatry Queen Elizabeth Hospital
1994–1998
Mayo Clinic College of Medicine and Science
1991–1994
Yangon General Hospital
1990–1991
University of Vermont
University of Medicine
1986–1990

Research

Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma
Clinical Cancer Research · 2013 · 239 citations
Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes
Scientific Reports · 2016 · 205 citations
Organ-Derived Decellularized Extracellular Matrix: A Game Changer for Bioink Manufacturing?
Review · Trends in biotechnology · 2018 · 174 citations

LJ
Liuyan Jiang
33 papers
Muhamad Moustafa
21 papers · 16 as a fellow
Allison Rosenthal
18 papers
Madiha Iqbal
18 papers · 3 as a fellow
DM
David Menke
16 papers
Ernesto Ayala
15 papers
Patrick Johnston
15 papers
Mohamed Dabaja
14 papers
Thomas Habermann
11 papers
Stephen Ansell
10 papers
Brad Hoppe
9 papers
Justin Kuhlman
9 papers · 9 as a resident

Grants

Osteopontin-Targeted Therapy for Primary CNS Lymphoma
National Cancer Institute · R41
PI · $284K · Modulation Therapeutics, Inc.
2017–2019
Osteopontin-Mediated Invasion and Dissemination in Central Nervous System Lymphom
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $419.5K · Mayo Clinic Jacksonville
2012–2014

Clinical trials

Nivolumab and Pomalidomide in Treating Patients With Relapsed or Refractory Central Nervous System Diffuse Large B Cell Lymphoma or Primary Vitreoretinal Diffuse Large B Cell Lymphoma
Principal investigator · Completed · Phase 1
Mayo Clinic
2019–2021
Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma
Principal investigator · Completed · Phase 1
Mayo Clinic
2013–2019
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Principal investigator · Completed · Phase 2
Mayo Clinic
2008–2017
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Site PI · Recruiting · Phase 3
Ono Pharmaceutical Co., Ltd.
2026–2029